Dalfopristin and Quinupristin Injection Shortage
Last Updated: September 26, 2022
Status: Current
Products Affected - Description
-
- Synercid lyophilized powder for injection, Pfizer, 350 mg/150 mg, vial, 10 count, NDC 61570-0260-10 - discontinued
Reason for the Shortage
-
- Pfizer discontinued Synercid in early-2022.
- There are no other suppliers of the product.
Available Products
-
- There are no presentations available
Estimated Resupply Dates
-
- Pfizer has discontinued Synercid.
Updated
Updated September 26, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 8, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.